Sensitive ASX Announcement

Invex Receives UK Approval to Commence Phase III Trial

Published: 29/06/22, 08:29am (AEST)3 pages
Invex Therapeutics Ltd
IXC:ASXHealthcare

Recent IXC Announcements

Price Sensitive only